We use cookies for a better user experience. Read our Privacy Policy

I Agree

Stem Cells Market

Stem Cells Market (Product Type: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, and Others; Source: Autologous and Allogenic; Application: Regenerative Medicines [Neurology, Oncology, Cardiology, and Others] and Drug Discovery & Development; and End-user: Therapeutics Companies, Cell & Tissue Banks, Tools & Reagents Companies, and Service Companies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Stem Cells Market Outlook 2028

  • The global stem cells market was valued over US$ 11.73 Bn in 2020
  • It is estimated to expand at a CAGR of 10.4% from 2021 to 2028
  • The global stem cells market is expected to reach the value of US$ 25.68 Bn by the end of 2028

Analysts’ Viewpoint on Stem Cells Market Scenario

Stem cells are used in treating various illnesses in the body. Technological advancements in healthcare and pharmaceutical industries are creating potential revenue opportunities for market players operating in the stem cells market. Increasing investments in R&D activities to explore innovative ways to use stem cells for different healthcare applications are driving the global stem cells market. The growing incidences of diseases such as cancer, diabetes, and heart diseases boost the demand for stem cells. Market players are exploring new approaches to culturing or utilizing stem cells in various applications. Rapid expansion of pharmaceutical companies and clinical research institutes in developed regions is fueling the growth of the market. High cost is a major factor affecting the growth of the global stem cells market. Companies in the stem cells market should experiment with new techniques to improvise the testing processes.

Increasing Demand for Stem Cells in Regenerative Medicines Accelerates Market Growth

The global stem cells market is majorly driven by rising applications of stem cells in regenerative medicines. Increase in the number of chronic diseases such as cardiac diseases, diabetes, cancer, etc. across the globe is responsible for market growth. Regenerative medicines are used in the treatment of various diseases, and are made using stem cells in order to repair an injured tissue. The rising clinical trials for regenerative medicines, along with increasing development in stem cell-based therapies is the factor creating value-grab opportunities for the market players. Companies operating in the global stem cells market are conducting basic research and preclinical trials for testing the regenerative capacity of stem cells in the treatment of various neurological conditions. With consistent efforts of scientists and R&D activities in stem cell biologics, market players are gaining lucrative growth opportunities in the global market.

To know the scope of our report Get a Sample on Stem Cells Market

Rising Healthcare Expenditure and Increasing Investment in R&D Activities

There has been a lot of research & development activities in the field of stem cells biologics. The high demand for stem cells in therapeutic treatments for neurological disorders, cancer, heart diseases, diabetes, etc. is driving the global market, creating lucrative revenue opportunities for manufacturers in the stem cells market. Governments are taking steps to support pharmaceutical companies, and investing in research and development activities. Manufacturers are bolstering their R&D capabilities to experiment with new technologies and applications. Manufacturers operating in the global stem cells market are using technological innovations to stay ahead of the competition and generate more revenue opportunities. Increasing healthcare expenditure, research & development activities, and trending advances in biologics strengthen the scope and expansion of the stem cells market.

Get a glimpse of the in-depth analysis through our Report Brochure

Increase in Funding for Stem Cell Research Generates Potential Opportunities

Increasing applications of stem cells for many health conditions and chronic diseases that affect millions of people globally. Consistent research in the field of stem cells is one of the key factors driving the growth of the market. Funding provided by governments and other private organizations to carry out extensive research on stem cells are encouraging market stakeholders to pave their ways in the global market by providing treatment for various chronic illnesses. The stem cells market is expected to witness abundance of growth opportunities in the upcoming years. The increasing number of chronic illnesses is anticipated to revive the growth of the stem cells market.

Expanding operations in future? To get the perfect launch ask for a custom report

North America Market Players Offering Profitable Revenue Opportunities

North America is expected to account for a major share of the global stem cells market during the forecast period. The North America stem cells market is majorly driven by increasing prevalence of lifestyle diseases such as diabetes, cancer, heart diseases, etc. in the region. In addition, technological advancements in healthcare, increasing investment on research & development activities, and growing number of diagnostic facilities are some of the key factors fueling market growth in North America. Manufacturers operating in the stem cells market are shifting toward electronics medical devices to increase the performance of services. Countries in Asia Pacific such as China and India are responsible for the fastest growth of the stem cells market in the region. Moreover, rapid urbanization and increasing spending on healthcare are factors contributing to the market growth in Asia Pacific.

Stem Cells Market: Overview

  • According to Transparency Market Research’s latest report on the global stem cells market for the historical period 2017–2019 and forecast period 2021–2028, Increasing health care expenditure in developing countries is projected to drive the global stem cells market during the forecast period

Increase in Funding for Stem Cell Research: Key Driver

  • Stem cells hold the promise for treatments and cures of more than 70 major diseases and conditions that affect millions of people globally. Several private and government sectors support funding for stem cell research.
    • According to Change.org, Inc., in the U.S., 64% of the people support federal funding of research on chronic diseases using stem cells taken from human embryos
  • Internationally, stem cell research is supported by significant government investments, with Asia being one of the most favorable regions. Stem cell research funding by the National Institutes of Health (NIH) has been increasing in the past few years.

Rise in Stem Cell Banking Services to Boost Market Growth

  • Umbilical cord blood provides a pool of hematopoietic and mesenchymal stem cells, which can be stored after childbirth for later use. The stored blood finds applications in treatment of hematological disorders such as leukemia, lymphoma, and sickle cell anemia.
  • The cost of storage is high, and according to the American Academy of Pediatrics, the odds that a person will require cord blood stem cells are 1:1,000
  • Nevertheless, parents opt for the storage and over 20,000 people in the U.S. have undergone surgeries, which have utilized stored umbilical cord blood

High Treatment Cost to Hamper Market

  • Stem cell treatment is expensive; major proportion of the global population cannot afford it
    • For instance, a full treatment with Prochymal, a stem cell-based drug approved in Canada to alleviate pediatric rejection of bone marrow transplants, is estimated to cost around US$ 200,000
    • This substantiates the fact that only a small proportion of population of the world is capable of spending on stem cell therapies

Stem Cells Market: Competition Landscape

  • This report profiles major players in the global stem cells market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global stem cells market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global stem cells market are
    • STEMCELL Technologies, Inc.
    • Astellas Pharma, Inc.
    • Cellular Engineering Technologies, Inc.
    • BioTime, Inc.
    • Takara Bio, Inc.
    • U.S. Stem Cell, Inc.
    • BrainStorm Cell Therapeutics, Inc.
    • Cytori Therapeutics, Inc.
    • Osiris Therapeutics, Inc.
    • Caladrius Biosciences, Inc., among others

Stem Cells Market: Key Developments

  • Key players in the global stem cells market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global stem cells market. A few expansion strategies adopted by players operating in the global stem cells market are:
    • In February 2018, Astellas Pharma, Inc. acquired Universal Cells, Inc. in order to utilize technology to produce pluripotent stem cells
    • In March 2021, OrganaBio introduced HematoPAC ASC-cb CD34 hematopoietic stem cell product in order to support the HSC-based allogeneic cell therapies
  • The report on the global stem cells market discusses individual strategies, followed by company profiles of manufacturers of stem cell products. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global stem cells market.

Stem Cells Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 11.73 Bn

Market Forecast Value in 2028

US$ 25.68 Bn

Growth Rate (CAGR)

10.4%

Forecast Period

2021–2028

Quantitative Units

US$ Bn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market Share Analysis by Company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • By Type
    • Adult Stem Cell
    • Human Embryonic Stem Cell
    • Induced Pluripotent Stem Cell
    • Others
  • By Source
    • Autologous
    • Allogenic
  • By Application
    • Regenerative Medicines
      • Neurology
      • Oncology
      • Cardiology
      • Others
    • Drug Discovery & Development
  • By End-user
    • Therapeutics Companies
    • Cell & Tissue Banks
    • Tools & Reagents Companies
    • Service Companies

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • STEMCELL Technologies, Inc.
  • Astellas Pharma, Inc.
  • Cellular Engineering Technologies, Inc.
  • BioTime, Inc.
  • Takara Bio, Inc.
  • U.S. Stem Cell, Inc.
  • BrainStorm Cell Therapeutics, Inc.
  • Cytori Therapeutics, Inc.
  • Osiris Therapeutics, Inc.
  • Caladrius Biosciences, Inc.
  • Others

Customization Scope

Available upon request

Pricing

Available upon request

Stem Cells Market – Segmentation

Product Type
  • Adult Stem Cell
  • Human Embryonic Stem Cell
  • Induced Pluripotent Stem Cell
  • Others
Source
  • Autologous
  • Allogenic
Application
  • Regenerative Medicines
    • Neurology
    • Oncology
    • Cardiology
    • Others
  • Drug Discovery & Development
End-user
  • Therapeutics Companies
  • Cell & Tissue Banks
  • Tools & Reagents Companies
  • Service Companies
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of stem cells market?

The global stem cells market was worth US$ 11.73 Bn and is projected to reach a value of US$ 25.68 Bn by the end of 2028

What is the anticipated CAGR of the stem cells market in the forecast period?

Stem cells market is anticipated to grow at a CAGR of 10.4% during the forecast period

Which region is expected to project the highest market share in the global stem cells market?

North America accounted for a major share of the global stem cells market

What are the key driving factors for the growth of the stem cells market?

Stem cells market is majorly driven by rising applications of stem cells in regenerative medicines, Increase in the number of chronic diseases such as cardiac diseases, diabetes, cancer, etc. across the globe is responsible for market growth

Who are the key players in the global stem cells market?

Key players in the global stem cells market include STEMCELL Technologies, Inc., Astellas Pharma, Inc., Cellular Engineering Technologies, Inc., BioTime, Inc., Takara Bio, Inc., U.S. Stem Cell, Inc., BrainStorm Cell Therapeutics, Inc., Cytori Therapeutics, Inc., Osiris Therapeutics, Inc., and Caladrius Biosciences, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Stem Cells Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Stem Cells Market Analysis and Forecast, 2017–2028

        4.4.1. Market Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections

5. Key Insights

    5.1. Disease Prevalence & Incidence Rate globally with key countries

    5.2. Key Industry Developments

    5.3. Pipeline Analysis

    5.4. COVID-19 Impact Analysis

6. Global Stem Cells Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product Type, 2017–2028

        6.3.1. Adult Stem Cell

        6.3.2. Human Embryonic Stem Cell

        6.3.3. Induced Pluripotent Stem Cell

        6.3.4. Others

    6.4. Market Attractiveness Analysis, by Product Type

7. Global Stem Cells Market Analysis and Forecast, by Source

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Source, 2017–2028

        7.3.1. Autologous

        7.3.2. Allogenic

    7.4. Market Attractiveness Analysis, by Source

8. Global Stem Cells Market Analysis and Forecast, by Application

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Application, 2017–2028

        8.3.1. Regenerative Medicines

            8.3.1.1. Neurology

            8.3.1.2. Oncology

            8.3.1.3. Cardiology

            8.3.1.4. Others

        8.3.2. Drug Discovery & Development

    8.4. Market Attractiveness Analysis, by Application

9. Global Stem Cells Market Analysis and Forecast, by End-user

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by End-user, 2017–2028

        9.3.1. Therapeutics Companies

        9.3.2. Cell & Tissue Banks

        9.3.3. Tools & Reagents Companies

        9.3.4. Service Companies

    9.4. Market Attractiveness Analysis, by End-user

10. Global Stem Cells Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness Analysis, by Country/Region

11. North America Stem Cells Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2017–2028

        11.2.1. Adult Stem Cell

        11.2.2. Human Embryonic Stem Cell

        11.2.3. Induced Pluripotent Stem Cell

        11.2.4. Others

    11.3. Market Value Forecast, by Source, 2017–2028

        11.3.1. Autologous

        11.3.2. Allogenic

    11.4. Market Value Forecast, by Application, 2017–2028

        11.4.1. Regenerative Medicines

            11.4.1.1. Neurology

            11.4.1.2. Oncology

            11.4.1.3. Cardiology

            11.4.1.4. Others

        11.4.2. Drug Discovery & Development

    11.5. Market Value Forecast, by End-user, 2017–2028

        11.5.1. Therapeutics Companies

        11.5.2. Cell & Tissue Banks

        11.5.3. Tools & Reagents Companies

        11.5.4. Service Companies

    11.6. Market Value Forecast, by Country, 2017–2028

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1. By Product Type

        11.7.2. By Source

        11.7.3. By Application

        11.7.4. By End-user

        11.7.5. By Country

12. Europe Stem Cells Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product Type, 2017–2028

        12.2.1. Adult Stem Cell

        12.2.2. Human Embryonic Stem Cell

        12.2.3. Induced Pluripotent Stem Cell

        12.2.4. Others

    12.3. Market Value Forecast, by Source, 2017–2028

        12.3.1. Autologous

        12.3.2. Allogenic

    12.4. Market Value Forecast, by Application, 2017–2028

        12.4.1. Regenerative Medicines

            12.4.1.1. Neurology

            12.4.1.2. Oncology

            12.4.1.3. Cardiology

            12.4.1.4. Others

        12.4.2. Drug Discovery & Development

    12.5. Market Value Forecast, by End-user, 2017–2028

        12.5.1. Therapeutics Companies

        12.5.2. Cell & Tissue Banks

        12.5.3. Tools & Reagents Companies

        12.5.4. Service Companies

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2028

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Italy

        12.6.5. Spain

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1. By Product Type

        12.7.2. By Source

        12.7.3. By Application

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific Stem Cells Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product Type, 2017–2028

        13.2.1. Adult Stem Cell

        13.2.2. Human Embryonic Stem Cell

        13.2.3. Induced Pluripotent Stem Cell

        13.2.4. Others

    13.3. Market Value Forecast, by Source, 2017–2028

        13.3.1. Autologous

        13.3.2. Allogenic

    13.4. Market Value Forecast, by Application, 2017–2028

        13.4.1. Regenerative Medicines

            13.4.1.1. Neurology

            13.4.1.2. Oncology

            13.4.1.3. Cardiology

            13.4.1.4. Others

        13.4.2. Drug Discovery & Development

    13.5. Market Value Forecast, by End-user, 2017–2028

        13.5.1. Therapeutics Companies

        13.5.2. Cell & Tissue Banks

        13.5.3. Tools & Reagents Companies

        13.5.4. Service Companies

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2028

        13.6.1. Japan

        13.6.2. China

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of APAC

    13.7. Market Attractiveness Analysis

        13.7.1. By Product Type

        13.7.2. By Source

        13.7.3. By Application

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America Stem Cells Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product Type, 2017–2028

        14.2.1. Adult Stem Cell

        14.2.2. Human Embryonic Stem Cell

        14.2.3. Induced Pluripotent Stem Cell

        14.2.4. Others

    14.3. Market Value Forecast, by Source, 2017–2028

        14.3.1. Autologous

        14.3.2. Allogenic

    14.4. Market Value Forecast, by Application, 2017–2028

        14.4.1. Regenerative Medicines

            14.4.1.1. Neurology

            14.4.1.2. Oncology

            14.4.1.3. Cardiology

            14.4.1.4. Others

        14.4.2. Drug Discovery & Development

    14.5. Market Value Forecast, by End-user, 2017–2028

        14.5.1. Therapeutics Companies

        14.5.2. Cell & Tissue Banks

        14.5.3. Tools & Reagents Companies

        14.5.4. Service Companies

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2028

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of LATAM

    14.7. Market Attractiveness Analysis

        14.7.1. By Product Type

        14.7.2. By Source

        14.7.3. By Application

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

15. Middle East & Africa Stem Cells Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Product Type, 2017–2028

        15.2.1. Adult Stem Cell

        15.2.2. Human Embryonic Stem Cell

        15.2.3. Induced Pluripotent Stem Cell

        15.2.4. Others

    15.3. Market Value Forecast, by Source, 2017–2028

        15.3.1. Autologous

        15.3.2. Allogenic

    15.4. Market Value Forecast, by Application, 2017–2028

        15.4.1. Regenerative Medicines

            15.4.1.1. Neurology

            15.4.1.2. Oncology

            15.4.1.3. Cardiology

            15.4.1.4. Others

        15.4.2. Drug Discovery & Development

    15.5. Market Value Forecast, by End-user, 2017–2028

        15.5.1. Therapeutics Companies

        15.5.2. Cell & Tissue Banks

        15.5.3. Tools & Reagents Companies

        15.5.4. Service Companies

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2028

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of MEA

    15.7. Market Attractiveness Analysis

        15.7.1. By Product Type

        15.7.2. By Source

        15.7.3. By Application

        15.7.4. By End-user

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player - Competition Matrix (by tier and size of companies)

    16.2. Market Share/Ranking Analysis, by Company, 2020

    16.3. Company Profiles

        16.3.1. STEMCELL Technologies, Inc.

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Financial Overview

            16.3.1.3. Product Portfolio

            16.3.1.4. SWOT Analysis

            16.3.1.5. Strategic Overview

        16.3.2. Astellas Pharma, Inc.

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Financial Overview

            16.3.2.3. Product Portfolio

            16.3.2.4. SWOT Analysis

            16.3.2.5. Strategic Overview

        16.3.3. Cellular Engineering Technologies, Inc.

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Financial Overview

            16.3.3.3. Product Portfolio

            16.3.3.4. SWOT Analysis

            16.3.3.5. Strategic Overview

        16.3.4. BioTime, Inc.

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Financial Overview

            16.3.4.3. Product Portfolio

            16.3.4.4. SWOT Analysis

            16.3.4.5. Strategic Overview

        16.3.5. Takara Bio, Inc.

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Financial Overview

            16.3.5.3. Product Portfolio

            16.3.5.4. SWOT Analysis

            16.3.5.5. Strategic Overview

        16.3.6. U.S. Stem Cell, Inc.

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Financial Overview

            16.3.6.3. Product Portfolio

            16.3.6.4. SWOT Analysis

            16.3.6.5. Strategic Overview

        16.3.7. BrainStorm Cell Therapeutics, Inc.

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Financial Overview

            16.3.7.3. Product Portfolio

            16.3.7.4. SWOT Analysis

            16.3.7.5. Strategic Overview

        16.3.8. Cytori Therapeutics, Inc.

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Financial Overview

            16.3.8.3. Product Portfolio

            16.3.8.4. SWOT Analysis

            16.3.8.5. Strategic Overview

        16.3.9. Osiris Therapeutics, Inc.

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Financial Overview

            16.3.9.3. Product Portfolio

            16.3.9.4. SWOT Analysis

            16.3.9.5. Strategic Overview

        16.3.10. Caladrius Biosciences, Inc.

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Financial Overview

            16.3.10.3. Product Portfolio

            16.3.10.4. SWOT Analysis

            16.3.10.5. Strategic Overview

        16.3.11. Other Prominent Players

List of Table

Table 01: Global Stem Cells Market Size (US$ Mn) Forecast, by Product Type, 2017–2028

Table 02: Global Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

Table 03: Global Stem Cells Market Size (US$ Mn) Forecast, by Application, 2017–2028

Table 04: Global Stem Cells Market Size (US$ Mn) Forecast, by Application – Regenerative Medicine, 2017–2028

Table 05: Global Stem Cells Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 06: Global Stem Cells Market Size (US$ Mn) Forecast, by Region, 2017–2028

Table 07: North America Stem Cells Market Size (US$ Mn) Forecast, by Country, 2017–2028

Table 08: North America Stem Cells Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 09: North America Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

Table 10: North America Stem Cells Market Size (US$ Mn) Forecast, by Application, 2017–2028

Table 11: North America Stem Cells Market Size (US$ Mn) Forecast, by Regenerative Medicine, 2017–2028

Table 12: North America Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

Table 13: Europe Stem Cells Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 14: Europe Stem Cells Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 15: Europe Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

Table 16: Europe Stem Cells Market Size (US$ Mn) Forecast, by Application, 2017–2028

Table 17: Europe Stem Cells Market Size (US$ Mn) Forecast, by Regenerative Medicine, 2017–2028

Table 18: Europe Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

Table 19: Asia Pacific Stem Cells Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 20: Asia Pacific Stem Cells Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 21: Asia Pacific Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

Table 22: Asia Pacific Stem Cells Market Size (US$ Mn) Forecast, by Application, 2017–2028

Table 23: Asia Pacific Stem Cells Market Size (US$ Mn) Forecast, by Regenerative Medicine, 2017–2028

Table 24: Asia Pacific Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

Table 25: Latin America Stem Cells Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 26: Latin America Stem Cells Market Size (US$ Mn) Forecast, by Product Type, 2017–2028

Table 27: Latin America Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

Table 28: Latin America Stem Cells Market Size (US$ Mn) Forecast, by Application, 2017–2028

Table 29: Latin America Stem Cells Market Size (US$ Mn) Forecast, by Application – Regenerative Medicine, 2017–2028

Table 30: Latin America Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

Table 31: Middle East & Africa Stem Cells Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 32: Middle East & Africa Stem Cells Market Size (US$ Mn) Forecast, by Product Type, 2017–2028

Table 33: Middle East & Africa Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

Table 34: Middle East & Africa Stem Cells Market Size (US$ Mn) Forecast, by Application, 2017–2028

Table 35: Middle East & Africa Stem Cells Market Size (US$ Mn) Forecast, by Application – Regenerative Medicine, 2017–2028

Table 36: Middle East & Africa Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

List of Figure

Figure 01: Global Stem Cells Market Snapshot

Figure 02: Revenue Share (2020)

Figure 03: Key Market Developments

Figure 04: Market Value Share, by Product, 2020

Figure 05: Market Value Share, by Source, 2020

Figure 06: Market Value Share, by Application, 2020

Figure 07: Market Value Share, by Source, 2020

Figure 08: Global Stem Cells Market Value Share Analysis, by Product Type, 2017 and 2028

Figure 09: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y growth (%) Forecast, by Adult Stem Cell, 2017–2028

Figure 10: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y growth (%) Forecast, by Human Embryonic Stem Cell, 2017–2028

Figure 11: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y growth (%) Forecast, by Induced Pluripotent Stem Cell, 2017–2028

Figure 12: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y growth (%) Forecast, by Others, 2017–2028

Figure 13: Global Stem Cells Market Attractiveness Analysis, by Product Type, 2017–2028

Figure 14: Global Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

Figure 15: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Autologous, 2017–2028

Figure 16: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Allogeneic, 2017–2028

Figure 17: Global Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

Figure 18: Global Stem Cells Market Value Share Analysis, by Application, 2017 and 2028

Figure 19: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Regenerative Medicine, 2017–2028

Figure 20: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Discovery & Development, 2017–2028

Figure 21: Global Stem Cells Market Attractiveness Analysis, by Application, 2017–2028

Figure 22: Global Stem Cells Market Value Share Analysis, by End-user, 2017 and 2028

Figure 23: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutics Companies, 2017–2028

Figure 24: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y growth (%) Growth Forecast, by Cell & Tissue Banks, 2017–2028

Figure 25: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Tools & Reagents Companies, 2017–2028

Figure 26: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Service Companies, 2017–2028

Figure 27: Global Stem Cells Market Attractiveness Analysis, by End-user, 2017–2028

Figure 28: Global Stem Cells Market Value Share Analysis, by Region, 2017 and 2028

Figure 29: Global Stem Cells Market Attractiveness Analysis, by Region, 2017–2028

Figure 30: North America Stem Cell Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2017–2028

Figure 31: North America Stem Cell Market Attractiveness Analysis, by Country, 2017-2028

Figure 32: North America Stem Cells Market Value Share Analysis, by Country, 2017 and 2028

Figure 33: North America Stem Cells Market Value Share Analysis, by Product, 2017 and 2028

Figure 34: North America Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

Figure 35: North America Stem Cells Market Value Share Analysis, by Application, 2017 and 2028

Figure 36: North America Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

Figure 37: North America Stem Cells Market Attractiveness Analysis, by Product, 2017–2028

Figure 38: North America Stem Cells Market Attractiveness Analysis, by Application, 2017–2028

Figure 39: North America Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

Figure 40: North America Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

Figure 41: Europe Stem Cells Market Size (US$ Mn) and Y-o-Y growth (%) Forecast, 2017–2028

Figure 42: Europe Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2017-2028

Figure 43: Europe Stem Cells Market Value Share Analysis, by Country/Sub-region, 2017 and 2028

Figure 44: Europe Stem Cells Market Value Share Analysis, by Product, 2017 and 2028

Figure 45: Europe Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

Figure 46: Europe Stem Cells Market Value Share Analysis, by Application, 2017 and 2028

Figure 47: Europe Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

Figure 48: Europe Stem Cells Market Attractiveness Analysis, by Product, 2017–2028

Figure 49: Europe Stem Cells Market Attractiveness Analysis, by Application, 2017–2028

Figure 50: Europe Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

Figure 51: Europe Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

Figure 52: Asia Pacific Stem Cells Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2017–2028

Figure 53: Asia Pacific Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2017-2028

Figure 54: Asia Pacific Stem Cells Market Value Share Analysis, by Country/Sub-region, 2017 and 2028

Figure 55: Asia Pacific Stem Cells Market Value Share Analysis, by Product, 2017 and 2028

Figure 56: Asia Pacific Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

Figure 57: Asia Pacific Stem Cells Market Value Share Analysis, by Application, 2017 and 2028

Figure 58: Asia Pacific Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

Figure 59: Asia Pacific Stem Cells Market Attractiveness Analysis, by Product, 2017–2028

Figure 60: Asia Pacific Stem Cells Market Attractiveness Analysis, by Application, 2017–2028

Figure 61: Asia Pacific Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

Figure 62: Asia Pacific Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

Figure 63: Latin America Stem Cells Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2017–2028

Figure 64: Latin America Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2017-2028

Figure 65: Latin America Stem Cells Market Value Share Analysis, by Country/Sub-region, 2017 and 2028

Figure 66: Latin America Stem Cells Market Value Share Analysis, by Product Type, 2017 and 2028

Figure 67: Latin America Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

Figure 68: Latin America Stem Cells Market Value Share Analysis, by Application, 2017 and 2028

Figure 69: Latin America Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

Figure 70: Latin America Stem Cells Market Attractiveness Analysis, by Product Type, 2017–2028

Figure 71: Latin America Stem Cells Market Attractiveness Analysis, by Application, 2017–2028

Figure 72: Latin America Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

Figure 73: Latin America Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

Figure 74: Middle East & Africa Stem Cells Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2017–2028

Figure 75: Middle East & Africa Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2017-2028

Figure 76: Middle East & Africa Stem Cells Market Value Share Analysis, by Country/Sub-region, 2017 and 2028

Figure 77: Middle East & Africa Stem Cells Market Value Share Analysis, by Product Type, 2017 and 2028

Figure 78: Middle East & Africa Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

Figure 79: Middle East & Africa Stem Cells Market Value Share Analysis, by Application, 2017 and 2028

Figure 80: Middle East & Africa Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

Figure 81: Middle East & Africa Stem Cells Market Attractiveness Analysis, by Product Type, 2017–2028

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved